|4Nov 2, 5:03 PM ET

Gold Lawrence Marshall 4

4 · 180 Life Sciences Corp. · Filed Nov 2, 2022

Insider Transaction Report

Form 4
Period: 2022-10-31
Transactions
  • Award

    Common Stock

    2022-10-31+30,70265,798 total
Footnotes (1)
  • [F1]Issued in consideration for serving on the Board of Directors, as a Member of the Audit and Compensation Committee of the Board of Directors, and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended September 30, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT